Published in J Mol Endocrinol on October 01, 2006
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol (2002) 2.55
A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res (2004) 1.67
Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum Gene Ther (2002) 1.27
Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer. Biochem Biophys Res Commun (2004) 1.19
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. J Am Coll Cardiol (2010) 1.17
Obesity-related changes in high-density lipoprotein metabolism. Obesity (Silver Spring) (2008) 1.13
Complement is an essential component of the immune response to adeno-associated virus vectors. J Virol (2008) 1.11
Expression of human scavenger receptor B1 on and in human platelets. Arterioscler Thromb Vasc Biol (2003) 1.10
Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes (2002) 1.08
Transcriptional control of apolipoprotein A-I gene expression in diabetes. Diabetes (2004) 1.02
The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels. Endocr Rev (2005) 0.94
Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling. Biochemistry (2006) 0.93
The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology (2002) 0.92
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3. Biochim Biophys Acta (2005) 0.91
A distinct thyroid hormone response element mediates repression of the human cholesterol 7alpha-hydroxylase (CYP7A1) gene promoter. Mol Endocrinol (2002) 0.88
HDL--is it too big to fail? Nat Rev Endocrinol (2013) 0.86
The role of calcium/calmodulin-dependent protein kinase cascade in glucose upregulation of insulin gene expression. Diabetes (2004) 0.85
Arterial embolization: a novel approach to thyroid ablative therapy for Graves' disease. J Clin Endocrinol Metab (2002) 0.85
Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta. Biochim Biophys Acta (2003) 0.84
Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes. Endocrine (2009) 0.84
Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells. FEBS Lett (2006) 0.83
High-density lipoprotein is a potential growth factor for adrenocortical cells. Biochem Biophys Res Commun (2006) 0.83
Insulin induction of apolipoprotein AI, role of Sp1. Biochemistry (2003) 0.83
Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells. Metabolism (2004) 0.82
Pancreatic glucokinase is activated by insulin-like growth factor-I. Endocrinology (2007) 0.81
24, 25-dihydroxycholecalciferol but not 25-hydroxycholecalciferol suppresses apolipoprotein A-I gene expression. Life Sci (2010) 0.80
Endoplasmic reticulum stress in HepG2 cells inhibits apolipoprotein A-I secretion. Life Sci (2012) 0.80
Thyrotropin-releasing hormone-stimulated thyrotropin expression involves islet-brain-1/c-Jun N-terminal kinase interacting protein-1. Endocrinology (2004) 0.80
Regulation of scavenger receptor class BI gene expression by angiotensin II in vascular endothelial cells. Hypertension (2007) 0.80
Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids. Obesity (Silver Spring) (2011) 0.79
Hyperglycemia suppresses hepatic scavenger receptor class B type I expression. Am J Physiol Endocrinol Metab (2007) 0.79
Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators. Biochim Biophys Acta (2007) 0.79
Inhibition of apolipoprotein A-I expression by TNF-alpha in HepG2 cells: requirement for c-jun. J Cell Biochem (2014) 0.78
Insulin-like growth factor-i regulation of hepatic scavenger receptor class BI. Endocrinology (2004) 0.78
Stilbene analogs as inducers of apolipoprotein-I transcription. Eur J Med Chem (2010) 0.78
Role of calcium-calmodulin-dependent protein kinase cascade in thyrotropin (TSH)-releasing hormone induction of TSH and prolactin gene expression. Endocrinology (2004) 0.77
Inhibition of apolipoprotein A-I gene by the aryl hydrocarbon receptor: a potential mechanism for smoking-associated hypoalphalipoproteinemia. Life Sci (2012) 0.77
Induction of the apolipoprotein AI promoter by Sp1 is repressed by saturated fatty acids. Metabolism (2004) 0.76
Induction of apolipoprotein A-I gene expression by glucagon-like peptide-1 and exendin-4 in hepatocytes but not intestinal cells. Metabolism (2012) 0.76
Effect of chromium on apolipoprotein A-I expression in HepG2 cells. Nutrition (2003) 0.76
Lipid-altering drugs: decreasing cardiovascular disease at the expense of increasing cancer? Cancer Res (2004) 0.75
Induction of apolipoprotein A-I gene expression by black seed (Nigella sativa) extracts. Pharm Biol (2014) 0.75
PREB regulates transcription of pancreatic glucokinase in response to glucose and cAMP. J Cell Mol Med (2009) 0.75
Apolipoprotein A-I expression in rats is not altered by troglitazone. Exp Biol Med (Maywood) (2002) 0.75
Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2. Metabolism (2004) 0.75
Effects of dehydroepiandrosterone on rat apolipoprotein AI gene expression in the human hepatoma cell line, HepG2. Metabolism (2002) 0.75